Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

Inclusion Criteria: * Both man and woman who is over 19 years old * Patient with dyslipidemia and hypertension * Written informed consent Exclusion Criteria: * Triglyceride ≥ 400 mg/dL at screening * Hypertensive patients who need antihypertensive medication except Amlodipine, β-blockers, RAS inhibitors * sSBP difference is ≥20 mmHg or sDBP difference is ≥10 mmHg * A history of rhabdomyolysis, myopathy * Patient with hypersensitivity to Statin or Amlodipine * Patients undergoing eGFR \<30 mL/min/1.73 m2 (MDRD) at screening * AST(Aspartate Aminotransferase) or ALT(Alanine Aminotransferase) level ≥ 3x ULN (upper limit of normal range) or active liver disease * Creatine kinase (CK) level ≥ 5x ULN (upper limit of normal range) * Contraindications stated in the Label of Rosuampin or Caduet * Those participating in other clinical trials for investigational products at screening * Patients deemed to be ineligible to participate in the trial by investigator